Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 43

1.

Pathway-based analysis of a melanoma genome-wide association study: analysis of genes related to tumour-immunosuppression.

Schoof N, Iles MM, Bishop DT, Newton-Bishop JA, Barrett JH; Genomel Consortium.

PLoS One. 2011;6(12):e29451. doi: 10.1371/journal.pone.0029451. Epub 2011 Dec 27.

2.

Short communication: Long-term survival of flag eartags on an Israeli dairy farm.

Seroussi E, Yakobson E, Garazi S, Oved Z, Halachmi I.

J Dairy Sci. 2011 Nov;94(11):5533-5. doi: 10.3168/jds.2011-4330.

PMID:
22032376
3.

Genome-wide association study identifies three new melanoma susceptibility loci.

Barrett JH, Iles MM, Harland M, Taylor JC, Aitken JF, Andresen PA, Akslen LA, Armstrong BK, Avril MF, Azizi E, Bakker B, Bergman W, Bianchi-Scarrà G, Bressac-de Paillerets B, Calista D, Cannon-Albright LA, Corda E, Cust AE, Dębniak T, Duffy D, Dunning AM, Easton DF, Friedman E, Galan P, Ghiorzo P, Giles GG, Hansson J, Hocevar M, Höiom V, Hopper JL, Ingvar C, Janssen B, Jenkins MA, Jönsson G, Kefford RF, Landi G, Landi MT, Lang J, Lubiński J, Mackie R, Malvehy J, Martin NG, Molven A, Montgomery GW, van Nieuwpoort FA, Novakovic S, Olsson H, Pastorino L, Puig S, Puig-Butille JA, Randerson-Moor J, Snowden H, Tuominen R, Van Belle P, van der Stoep N, Whiteman DC, Zelenika D, Han J, Fang S, Lee JE, Wei Q, Lathrop GM, Gillanders EM, Brown KM, Goldstein AM, Kanetsky PA, Mann GJ, Macgregor S, Elder DE, Amos CI, Hayward NK, Gruis NA, Demenais F, Bishop JA, Bishop DT; GenoMEL Consortium.

Nat Genet. 2011 Oct 9;43(11):1108-13. doi: 10.1038/ng.959.

4.

Genome-wide association study identifies novel loci predisposing to cutaneous melanoma.

Amos CI, Wang LE, Lee JE, Gershenwald JE, Chen WV, Fang S, Kosoy R, Zhang M, Qureshi AA, Vattathil S, Schacherer CW, Gardner JM, Wang Y, Bishop DT, Barrett JH; GenoMEL Investigators, MacGregor S, Hayward NK, Martin NG, Duffy DL; Q-Mega Investigators, Mann GJ, Cust A, Hopper J; AMFS Investigators, Brown KM, Grimm EA, Xu Y, Han Y, Jing K, McHugh C, Laurie CC, Doheny KF, Pugh EW, Seldin MF, Han J, Wei Q.

Hum Mol Genet. 2011 Dec 15;20(24):5012-23. doi: 10.1093/hmg/ddr415. Epub 2011 Sep 17.

5.

Polymorphisms in the NPY2R gene show significant associations with BMI that are additive to FTO, MC4R, and NPFFR2 gene effects.

Hunt SC, Hasstedt SJ, Xin Y, Dalley BK, Milash BA, Yakobson E, Gress RE, Davidson LE, Adams TD.

Obesity (Silver Spring). 2011 Nov;19(11):2241-7. doi: 10.1038/oby.2011.239. Epub 2011 Aug 4.

6.

Analysis of copy loss and gain variations in Holstein cattle autosomes using BeadChip SNPs.

Seroussi E, Glick G, Shirak A, Yakobson E, Weller JI, Ezra E, Zeron Y.

BMC Genomics. 2010 Nov 29;11:673. doi: 10.1186/1471-2164-11-673.

7.

Bovine mtDNA D-loop haplotypes exceed mutations in number despite reduced recombination: an effective alternative for identity control.

Seroussi E, Yakobson E.

Animal. 2010 Nov;4(11):1818-22. doi: 10.1017/S1751731110001151.

PMID:
22445142
8.

Selection criteria for genetic assessment of patients with familial melanoma.

Leachman SA, Carucci J, Kohlmann W, Banks KC, Asgari MM, Bergman W, Bianchi-Scarrà G, Brentnall T, Bressac-de Paillerets B, Bruno W, Curiel-Lewandrowski C, de Snoo FA, Debniak T, Demierre MF, Elder D, Goldstein AM, Grant-Kels J, Halpern AC, Ingvar C, Kefford RF, Lang J, MacKie RM, Mann GJ, Mueller K, Newton-Bishop J, Olsson H, Petersen GM, Puig S, Rigel D, Swetter SM, Tucker MA, Yakobson E, Zitelli JA, Tsao H.

J Am Acad Dermatol. 2009 Oct;61(4):677.e1-14. doi: 10.1016/j.jaad.2009.03.016. Review.

9.

The Y152X MC1R gene mutation: occurrence in ethnically diverse Jewish malignant melanoma patients.

Galore G, Azizi E, Scope A, Pavlotsky F, Yakobson E, Friedman E.

Melanoma Res. 2007 Apr;17(2):105-8.

PMID:
17496785
10.

High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL.

Goldstein AM, Chan M, Harland M, Gillanders EM, Hayward NK, Avril MF, Azizi E, Bianchi-Scarra G, Bishop DT, Bressac-de Paillerets B, Bruno W, Calista D, Cannon Albright LA, Demenais F, Elder DE, Ghiorzo P, Gruis NA, Hansson J, Hogg D, Holland EA, Kanetsky PA, Kefford RF, Landi MT, Lang J, Leachman SA, Mackie RM, Magnusson V, Mann GJ, Niendorf K, Newton Bishop J, Palmer JM, Puig S, Puig-Butille JA, de Snoo FA, Stark M, Tsao H, Tucker MA, Whitaker L, Yakobson E; Melanoma Genetics Consortium (GenoMEL).

Cancer Res. 2006 Oct 15;66(20):9818-28.

11.

Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents.

Goldstein AM, Chan M, Harland M, Hayward NK, Demenais F, Bishop DT, Azizi E, Bergman W, Bianchi-Scarra G, Bruno W, Calista D, Albright LA, Chaudru V, Chompret A, Cuellar F, Elder DE, Ghiorzo P, Gillanders EM, Gruis NA, Hansson J, Hogg D, Holland EA, Kanetsky PA, Kefford RF, Landi MT, Lang J, Leachman SA, MacKie RM, Magnusson V, Mann GJ, Bishop JN, Palmer JM, Puig S, Puig-Butille JA, Stark M, Tsao H, Tucker MA, Whitaker L, Yakobson E; Lund Melanoma Study Group; Melanoma Genetics Consortium (GenoMEL).

J Med Genet. 2007 Feb;44(2):99-106. Epub 2006 Aug 11.

12.

[Gene silencing RNAi technology: possible application to therapy].

Vestin A, Weinstein J, Davidov E, Sidi Y, Yakobson EA.

Harefuah. 2006 Feb;145(2):156-9, 163. Hebrew.

PMID:
16509424
13.

Search for germline alterations in CDKN2A/ARF and CDK4 of 42 Jewish melanoma families with or without neural system tumours.

Marian C, Scope A, Laud K, Friedman E, Pavlotsky F, Yakobson E, Bressac-de Paillerets B, Azizi E.

Br J Cancer. 2005 Jun 20;92(12):2278-85.

14.

Search for genetic variants associated with cutaneous malignant melanoma in the Ashkenazi Jewish population.

Loo JC, Paterson AD, Hao A, Shennan M, Peretz H, Sidi Y, Hogg D, Yakobson E.

J Med Genet. 2005 May;42(5):e30. No abstract available.

15.

A single Mediterranean, possibly Jewish, origin for the Val59Gly CDKN2A mutation in four melanoma-prone families.

Yakobson E, Eisenberg S, Isacson R, Halle D, Levy-Lahad E, Catane R, Safro M, Sobolev V, Huot T, Peters G, Ruiz A, Malvehy J, Puig S, Chompret A, Avril MF, Shafir R, Peretz H, Bressac-de Paillerets B.

Eur J Hum Genet. 2003 Apr;11(4):288-96.

16.

Two p16 (CDKN2A) germline mutations in 30 Israeli melanoma families.

Yakobson E, Shemesh P, Azizi E, Winkler E, Lassam N, Hogg D, Brookes S, Peters G, Lotem M, Zlotogorski A, Landau M, Safro M, Shafir R, Friedman E, Peretz H.

Eur J Hum Genet. 2000 Aug;8(8):590-6.

17.

The human platelet alphaIIb gene is not closely linked to its integrin partner beta3.

Thornton MA, Poncz M, Korostishevsky M, Yakobson E, Usher S, Seligsohn U, Peretz H.

Blood. 1999 Sep 15;94(6):2039-47.

18.

Screening for tumour suppressor p16(CDKN2A) germline mutations in Israeli melanoma families.

Yakobson EA, Zlotogorski A, Shafir R, Cohen M, Icekson M, Landau M, Brenner S, Usher S, Peretz H.

Clin Chem Lab Med. 1998 Aug;36(8):645-8.

PMID:
9806478
19.

Cys 618 Arg mutation in the RET proto-oncogene associated with familial medullary thyroid carcinoma and maternally transmitted Hirschsprung's disease suggesting a role for imprinting.

Peretz H, Luboshitsky R, Baron E, Biton A, Gershoni R, Usher S, Grynberg E, Yakobson E, Graff E, Lapidot M.

Hum Mutat. 1997;10(2):155-9.

PMID:
9259198
20.
Items per page

Supplemental Content

Loading ...
Write to the Help Desk